--2025/Q1-- / 31.058M--
--2024/Q4-- / 8.776M--
Nov 12, 20242024/Q33.695M / 4.863M--
Aug 13, 20242024/Q24.449M / 4.358M--
May 8, 20242024/Q13.425M / 3.759M--
US Stock MarketDetailed Quotes
ZVRA Zevra Therapeutics
- 9.580
- +0.090+0.95%
Trading Nov 26 11:19 ET
511.34MMarket Cap-4497P/E (TTM)
9.740High9.333Low102.34KVolume9.560Open9.490Pre Close984.76KTurnover0.24%Turnover RatioLossP/E (Static)53.38MShares9.76052wk High7.33P/B412.70MFloat Cap4.20052wk Low--Dividend TTM43.08MShs Float418.400Historical High--Div YieldTTM4.29%Amplitude2.560Historical Low9.622Avg Price1Lot Size
Zevra Therapeutics Key Stats
Zevra Therapeutics Q3 2024 Earnings Date
Currency：USDNov 12, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 4.86M | 3.70M | -1.17M |
| Miss Est. | +67.97% | +27.63% | -24.01% |
| EPS | -0.42 | -0.69 | -0.27 |
| Miss Est. | -5.33% | -130.00% | -63.82% |
Analyst Rating
Nov 14, 2024
Zevra Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Zevra Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data